{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:35:08Z","timestamp":1788298508646,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T00:00:00Z","timestamp":1336003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1748-717x-7-67","type":"journal-article","created":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T10:15:23Z","timestamp":1336040123000},"source":"Crossref","is-referenced-by-count":97,"title":["Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma"],"prefix":"10.1186","volume":"7","author":[{"given":"Brandon M","family":"Barney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Haddock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,3]]},"reference":[{"key":"602_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","volume":"234","author":"WR Jarnagin","year":"2001","unstructured":"Jarnagin WR, Fong Y, DeMatteo RP, et al.: Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001, 234: 507-517. discussion 517\u2013509 10.1097\/00000658-200110000-00010","journal-title":"Ann Surg"},{"key":"602_CR2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","volume":"242","author":"DJ Rea","year":"2005","unstructured":"Rea DJ, Heimbach JK, Rosen CB, et al.: Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005, 242: 451-458. discussion 458\u2013461","journal-title":"Ann Surg"},{"key":"602_CR3","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/cncr.11699","volume":"98","author":"WR Jarnagin","year":"2003","unstructured":"Jarnagin WR, Ruo L, Little SA, et al.: Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 2003, 98: 1689-1700. 10.1002\/cncr.11699","journal-title":"Cancer"},{"key":"602_CR4","doi-asserted-by":"publisher","first-page":"8739","DOI":"10.1200\/JCO.2005.01.5354","volume":"23","author":"E Ben-Josef","year":"2005","unstructured":"Ben-Josef E, Normolle D, Ensminger WD, et al.: Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol 2005, 23: 8739-8747. 10.1200\/JCO.2005.01.5354","journal-title":"J Clin Oncol"},{"key":"602_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S0360-3016(02)02845-6","volume":"53","author":"CH Crane","year":"2002","unstructured":"Crane CH, Macdonald KO, Vauthey JN, et al.: Limitations of conventional doses of chemoradiation for unresectable biliary cancer. Int J Radiat Oncol Biol Phys 2002, 53: 969-974. 10.1016\/S0360-3016(02)02845-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"602_CR6","doi-asserted-by":"publisher","first-page":"W205","DOI":"10.2214\/AJR.10.4937","volume":"196","author":"JH Kim","year":"2011","unstructured":"Kim JH, Won HJ, Shin YM, et al.: Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma. AJR Am J Roentgenol 2011, 196: W205-W209. 10.2214\/AJR.10.4937","journal-title":"AJR Am J Roentgenol"},{"key":"602_CR7","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/cncr.23787","volume":"113","author":"JH Kim","year":"2008","unstructured":"Kim JH, Yoon HK, Sung KB, et al.: Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes. Cancer 2008, 113: 1614-1622. 10.1002\/cncr.23787","journal-title":"Cancer"},{"key":"602_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s10620-011-1957-7","volume":"57","author":"Y Tomizawa","year":"2012","unstructured":"Tomizawa Y, Tian J: Photodynamic therapy for unresectable cholangiocarcinoma. Dig Dis Sci 2012, 57: 274-283. 10.1007\/s10620-011-1957-7","journal-title":"Dig Dis Sci"},{"key":"602_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/s-2004-828889","volume":"24","author":"Y Shaib","year":"2004","unstructured":"Shaib Y, El-Serag HB: The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004, 24: 115-125. 10.1055\/s-2004-828889","journal-title":"Semin Liver Dis"},{"key":"602_CR10","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/0360-3016(94)90115-5","volume":"28","author":"ME Alden","year":"1994","unstructured":"Alden ME, Mohiuddin M: The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. Int J Radiat Oncol Biol Phys 1994, 28: 945-951. 10.1016\/0360-3016(94)90115-5","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"602_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ijrobp.2005.07.977","volume":"64","author":"F Deodato","year":"2006","unstructured":"Deodato F, Clemente G, Mattiucci GC, et al.: Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results. Int J Radiat Oncol Biol Phys 2006, 64: 483-488. 10.1016\/j.ijrobp.2005.07.977","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"602_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ijrobp.2009.08.020","volume":"78","author":"KA Goodman","year":"2010","unstructured":"Goodman KA, Wiegner EA, Maturen KE, et al.: Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys 2010, 78: 486-493. 10.1016\/j.ijrobp.2009.08.020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"602_CR13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1200\/JCO.2001.19.1.164","volume":"19","author":"KK Herfarth","year":"2001","unstructured":"Herfarth KK, Debus J, Lohr F, et al.: Stereotactic single-dose radiation therapy of liver tumors: results of a phase I\/II trial. J Clin Oncol 2001, 19: 164-170.","journal-title":"J Clin Oncol"},{"key":"602_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.radonc.2009.11.004","volume":"94","author":"N Kopek","year":"2010","unstructured":"Kopek N, Holt MI, Hansen AT, et al.: Stereotactic body radiotherapy for unresectable cholangiocarcinoma. Radiother Oncol 2010, 94: 47-52. 10.1016\/j.radonc.2009.11.004","journal-title":"Radiother Oncol"},{"key":"602_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.radonc.2011.05.016","volume":"99","author":"FA Polistina","year":"2011","unstructured":"Polistina FA, Guglielmi R, Baiocchi C, et al.: Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience. Radiother Oncol 2011, 99: 120-123. 10.1016\/j.radonc.2011.05.016","journal-title":"Radiother Oncol"},{"key":"602_CR16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","volume":"26","author":"RV Tse","year":"2008","unstructured":"Tse RV, Hawkins M, Lockwood G, et al.: Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 2008, 26: 657-664. 10.1200\/JCO.2007.14.3529","journal-title":"J Clin Oncol"},{"key":"602_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al.: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009, 45: 228-247. 10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"602_CR18","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.gastro.2003.07.015","volume":"125","author":"ME Ortner","year":"2003","unstructured":"Ortner ME, Caca K, Berr F, et al.: Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 2003, 125: 1355-1363. 10.1016\/j.gastro.2003.07.015","journal-title":"Gastroenterology"},{"key":"602_CR19","volume-title":"American journal of clinical oncology","author":"BM Barney","year":"2011","unstructured":"Barney BM, Olivier KR, Macdonald OK, et al.: Clinical Outcomes and Dosimetric Considerations Using Stereotactic Body Radiotherapy for Abdominopelvic Tumors. American journal of clinical oncology 2011."},{"key":"602_CR20","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1118\/1.3438081","volume":"37","author":"SH Benedict","year":"2010","unstructured":"Benedict SH, Yenice KM, Followill D, et al.: Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 2010, 37: 4078-4101. 10.1118\/1.3438081","journal-title":"Med Phys"},{"key":"602_CR21","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","volume":"76","author":"CC Pan","year":"2010","unstructured":"Pan CC, Kavanagh BD, Dawson LA, et al.: Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 2010, 76: S94-S100. 10.1016\/j.ijrobp.2009.06.092","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"602_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11894-008-0022-y","volume":"9","author":"J Levitsky","year":"2007","unstructured":"Levitsky J, Sorrell MF: Hepatic complications of hematopoietic cell transplantation. Curr Gastroenterol Rep 2007, 9: 60-65. 10.1007\/s11894-008-0022-y","journal-title":"Curr Gastroenterol Rep"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-7-67.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1748-717X-7-67\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-7-67.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T20:09:35Z","timestamp":1642190975000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-7-67"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,3]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["602"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-7-67","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,3]]},"article-number":"67"}}